Organigram Global Inc.
OGI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001620737
No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 69
- 13F valueReported value at the end of Q2 2026
- $7.87M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OGI, Q2 2026
No superinvestor reported holding OGI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Organigram Global Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Organigram Global Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Organigram Global Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toroso Investments, LLC | 2,164,878 | $2.21M | 0.01% | −3,519−0.2% | Reduced |
| Renaissance Technologies LLC | 1,444,148 | $1.47M | 0.00% | −195,900−11.9% | Reduced |
| AdvisorShares Investments LLC | 888,057 | $905.8K | 0.11% | −59,383−6.3% | Reduced |
| Goldman Sachs Group Inc | 611,479 | $623.7K | 0.00% | +40,110+7.0% | Added |
| Morgan Stanley | 308,108 | $314.3K | 0.00% | −56,076−15.4% | Reduced |
| Baader Bank INC | 250,000 | $254.5K | 0.02% | −12,980−4.9% | Reduced |
| Bank of Montreal | 238,434 | $243.5K | 0.00% | +380+0.2% | Added |
| Formidable Asset Management, LLC | 160,311 | $214.8K | 0.03% | +3,562+2.3% | Added |
| UBS Group AG | 208,770 | $212.9K | 0.00% | +176,155+540.1% | Added |
| Leonteq Securities AG | 124,849 | $180.4K | 0.01% | −13,662−9.9% | Reduced |